TLDR
- Oklo (OKLO) stock climbed more than 13% following NRC approval of its Principal Design Criteria topical report for Idaho’s Aurora powerhouse reactor
- NRC expedited the review process, creating a more efficient pathway for future advanced reactor licensing applications
- Texas Capital Securities maintained its Buy recommendation with a $120 price target after the announcement
- The company’s Q1 2026 financial results are scheduled for release on May 12, providing additional momentum
- Peers including NuScale and Nano Nuclear experienced gains as the nuclear energy sector rallied in tandem
Shares of Oklo surged over 13% during Tuesday’s trading session after receiving critical regulatory approval from the U.S. Nuclear Regulatory Commission for a pivotal design framework tied to its Aurora powerhouse reactor being developed in Idaho.
The equity peaked at $79.03 intraday before settling near $78.45 as trading continued.
The regulatory body greenlit Oklo’s Principal Design Criteria topical report through an expedited evaluation timeline, signaling the commission’s commitment to modernizing approval frameworks for next-generation reactor technologies.
This PDC clearance establishes core safety, operational reliability, and performance benchmarks that will inform subsequent licensing procedures and engineering developments. Importantly, the approved document can now serve as a reference point in future submissions, eliminating redundant regulatory scrutiny.
Chief Executive Jacob DeWitte characterized the development as a significant achievement, noting the approval demonstrates “strong work by the Oklo team and timely engagement by the regulator.” He emphasized that “performance-based licensing, clear criteria, and efficient reviews are important to advancing modern nuclear projects safely and responsibly.”
Texas Capital Maintains Bullish Stance
Following the announcement, Texas Capital Securities analyst Nate Pendleton reaffirmed his Buy rating and $120 valuation target on Oklo. Pendleton characterized the PDC clearance as “another incremental step forward” while highlighting the “increasingly efficient regulatory path for advanced reactor solutions.”
The company currently enjoys a “Moderate Buy” rating consensus, bolstered by recent analytical coverage from Tigress Financial and HSBC.
The expedited NRC evaluation process stems directly from executive directives signed by President Trump in May 2025, designed to accelerate advanced nuclear energy initiatives. The approach also complements the ADVANCE Act, legislation intended to streamline deployment timelines for cutting-edge nuclear technologies.
Skeptics have historically questioned whether Oklo could navigate the complex regulatory landscape successfully. Tuesday’s NRC approval weakens that bearish argument, though additional clearances remain necessary before commercial launch.
As a pre-revenue enterprise, regulatory milestones serve as crucial indicators of operational progress for investors monitoring the company’s development trajectory.
Sector-Wide Nuclear Momentum
The positive price action extended beyond Oklo. NuScale Power and Nano Nuclear both recorded gains as nuclear energy stocks experienced consecutive rally days. Favorable market conditions provided additional support, with the S&P 500 advancing 1.08%, the Dow Jones climbing 1.07%, and the Nasdaq rising 1.46%.
Separate from its Idaho development, Oklo is collaborating with Meta Platforms on a 1.2 gigawatt nuclear energy initiative in Ohio designed to power Meta’s data center infrastructure in that region.
The company has scheduled its Q1 2026 earnings conference call for May 12.
